国产999免费视频|亚洲欧美激情综合首页|动漫人妻h无码中文字幕|国产精品欧美日韩视频一区|美女精品人妻视频一区二区|中文亲近交尾bd在线播放|色五月丁香亚洲高清无码国产|久久一区国产男人操女人的视频

position: EnglishChannel  > News> Tech-Finance Synergy Unlocks Innovation Potential

Tech-Finance Synergy Unlocks Innovation Potential

Source: Science and Technology Daily | 2025-07-01 18:22:28 | Author: LI Linxu

Thanks to strong policy support, a favorable market environment and a sound innovation ecosystem, the virtuous cycle of tech, capital and industry is gaining greater momentum in China.

While global IPO markets stagnate in year-to-date 2025 — with listings down 11 percent by volume worldwide, the Chinese mainland's A-share market and the Hong Kong exchanges have emerged as twin engines of growth.

Recent EY data reveals the Hong Kong exchanges' staggering 711 percent year-on-year fundraising leap in the first half of 2025, capturing 24 percent of global IPO capital, while the A-share market posted double digit growth in both deal volume and value.

By sector, the industrial, technology, and materials sectors took the top three spots in both IPO volume and fundraising amount in the A-share market. Notably, among the IPOs listed in the first half of 2025 in the A-share market, more than 30 percent of companies belonged to upstream and downstream enterprises in the automotive industry.

As EY Greater China IPO Leader Terence Ho noted, the technology attribute of the A-share market is becoming increasingly prominent, with capital markets rapidly converging towards sci-tech enterprises. Domestic industrial upgrading has driven increased listing and financing needs of sci-tech innovation companies. Premium sci-tech enterprises that meet listing requirements are expected to be prioritized in the pipeline, aligning more precisely with the real economy's demand for high-quality development.

Meanwhile, the China Securities Regulatory Commission (CSRC) has repeatedly emphasized stronger support for high-quality yet unprofitable tech companies to list, indicating that institutional dividends for sci-tech innovation firms are expected to materialize at a faster pace and the listing and financing environment will continue to optimize.

This is underscored by CSRC Chairman Wu Qing's pledge at the recent Lujiazui Forum in Shanghai to "empower the integration of tech and industrial innovation through deepening the opening up and reform of capital market."

Statistics show that listed enterprises have emerged as a core engine of sci-tech innovation. In 2024, the R&D expenditure of A-share listed entities reached 1.88 trillion RMB, accounting for more than 50 percent of national R&D investment.

The innovation trajectory—ignited by technology, scaled by industry, and monetized through capital—has become increasingly evident.

The EY report projects that in the second half of 2025, A-share IPO activities will intensify focus on the sci-tech innovation sector. The listing prospects for sci-tech innovation enterprises remain promising.

As the path forward requires deeper integration of financial infrastructure with innovation ecosystems, tech-finance synergy is no longer optional — it's the cornerstone of competitive economies.

Editor:李林旭

Top News

Jointly Protecting People's Rights in Digital Era

?Emerging technologies like AI, big data and the Internet of Things are rapidly reshaping the world in this era of digital intelligence. However, they are also bringing challenges to human rights, which makes joint efforts essential. Science and Technology Daily spoke with international experts on these issues against the backdrop of the 2025 China-Europe Seminar on Human Rights hosted by the China Society for Human Rights Studies and Cátedra China Foundation in Madrid, Spain, on June 25 on the theme "Human Rights in the Era of Digital Intelligence."

First Human Clinical Trial of Invasive BCI in China

A major breakthrough in neurotechnology has been achieved with the successful completion of China's first-in-human clinical trial of an invasive brain-computer interface (BCI) system. With that China becomes the second country in the world to reach the clinical stage in this field.

抱歉,您使用的瀏覽器版本過低或開啟了瀏覽器兼容模式,這會(huì)影響您正常瀏覽本網(wǎng)頁

您可以進(jìn)行以下操作:

1.將瀏覽器切換回極速模式

2.點(diǎn)擊下面圖標(biāo)升級(jí)或更換您的瀏覽器

3.暫不升級(jí),繼續(xù)瀏覽

繼續(xù)瀏覽
柘荣县| 鹿邑县| 西昌市| 苍南县| 邵东县| 社旗县| 聊城市| 静海县| 黄浦区| 宁津县| 隆林| 霸州市| 西贡区| 修水县| 鄯善县| 金华市| 泰兴市| 舞阳县| 邮箱| 武安市| 班玛县| 泽普县| 云南省| 莲花县| 无锡市| 封开县| 社旗县| 翁牛特旗| 洛扎县| 襄樊市| 宝应县| 余干县| 汉沽区| 炎陵县| 和静县| 阳城县| 金坛市| 南京市| 松原市| 西乌珠穆沁旗| 平武县|